A covered entity can email a patient whose GLP-1 prescription has lapsed without written authorization, as long as the email relates to the patient’s treatment and no third party whose product the email describes pays for it. If the email goes out within 90 calendar days of the prescription lapsing, the HHS treats it as a refill reminder, and a third party can cover the cost as long as the payment is reasonably related to what the covered entity spends sending it. After 90 days, the email has to fit a different exception, such as a treatment communication.